Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06
  • Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Precision Signal ...

    2026-03-24

    Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Precision Signal Amplification for Immunofluorescence Research

    Principle and Setup: Harnessing Fluorescent Signal Amplification

    The Cy3 Goat Anti-Mouse IgG (H+L) Antibody stands out as a cornerstone reagent for sensitive and quantitative detection of mouse primary antibodies in diverse immunoassays. Supplied by APExBIO, this affinity-purified polyclonal secondary antibody is conjugated to the Cy3 fluorescent dye, producing strong, photostable orange-red emission (excitation: 550 nm; emission: 570 nm). This spectral profile enables multiplexed imaging and is compatible with widely used filter sets, ensuring seamless integration into existing microscopy and flow cytometry workflows.

    The antibody specifically recognizes both heavy and light chains of mouse IgG, ensuring comprehensive detection of mouse-derived primary antibodies. Its immunoaffinity purification—using antigen-coupled agarose beads—yields high specificity and minimal background, critical for discerning subtle protein expression changes in complex samples such as tumor tissue sections or heterogeneous cell suspensions.

    Signal amplification is achieved through the multivalency of secondary antibody binding: multiple Cy3 conjugated secondary antibodies can attach to a single primary antibody, exponentially enhancing the fluorescent signal. This mechanism is pivotal for applications demanding high sensitivity, such as detection of low-abundance targets or spatially resolved protein mapping in the tumor microenvironment.

    Step-by-Step Workflow: Enhancing Immunoassays with Cy3 Conjugated Secondary Antibody

    Immunofluorescence Protocol: Key Enhancements

    1. Sample Preparation: Fix tissue or cells using paraformaldehyde (4% in PBS) for optimal antigen preservation. Permeabilize with 0.1% Triton X-100 if intracellular targets are probed.
    2. Blocking: Incubate samples in 1-3% BSA or serum from the host species of the secondary antibody (goat) to reduce non-specific binding.
    3. Primary Antibody Incubation: Apply mouse primary antibody at empirically determined concentrations (commonly 1-10 μg/mL) overnight at 4°C for maximal target engagement.
    4. Washing: Perform three washes with PBS or TBS containing 0.05% Tween-20 to remove unbound primary antibody.
    5. Secondary Antibody Incubation: Dilute the Cy3 Goat Anti-Mouse IgG (H+L) Antibody (typically 1:500–1:2000) in blocking buffer. Incubate for 1 hour at room temperature, protected from light.
    6. Final Washes: Wash three times to eliminate unbound secondary antibody, minimizing background fluorescence.
    7. Mounting and Imaging: Mount with anti-fade medium and image using a fluorescence microscope equipped with Cy3-compatible filters. Quantify signal using standardized exposure settings to enable reproducibility.

    For flow cytometry, after blocking and primary antibody incubation, dilute the secondary antibody to 0.5–2 μg per million cells. Incubate in the dark for 30 minutes on ice, followed by washes and analysis on a cytometer with a 561 nm laser for Cy3 detection.

    Western Blotting

    • After standard transfer and blocking steps, incubate the membrane with primary mouse antibody overnight at 4°C.
    • Apply the fluorescent secondary antibody for western blot (1:5000–1:10,000 dilution) for 1 hour at room temperature, shielded from light.
    • Visualize using a fluorescence imager with Cy3 settings, ensuring linearity of signal for quantification.

    These workflow enhancements—especially the use of immunoaffinity purified antibody and carefully optimized dilutions—consistently deliver low background and high target-to-noise ratios, even in challenging specimens such as highly autofluorescent tissues.

    Advanced Applications and Comparative Advantages in Tumor Microenvironment Studies

    Recent translational research highlights the critical role of the tumor microenvironment (TME) in therapeutic resistance. The landmark study by Xiong et al. (2024) demonstrated that cancer-associated fibroblasts (CAFs) drive enzalutamide resistance and PD-L1 upregulation in prostate cancer via the CCL5-CCR5 axis. Detailed protein localization and quantification in such studies depend on robust, multiplexed detection platforms.

    The Cy3 Goat Anti-Mouse IgG (H+L) Antibody is ideally suited for these advanced immunofluorescence, immunohistochemistry secondary antibody, and flow cytometry secondary antibody applications. Its high specificity and signal amplification capacity enable researchers to:

    • Precisely map spatial relationships between CAF markers (such as α-SMA, FAP) and immune checkpoint proteins (PD-L1) in tissue sections.
    • Quantify subtle changes in protein abundance following pharmacological blockade of the CCL5-CCR5 pathway, as shown by reduced PD-L1 expression in prostate tumors treated with maraviroc.
    • Perform high-throughput cell sorting of tumor and stromal cell populations using fluorescent secondary antibody for cell sorting, facilitating downstream transcriptomic or proteomic analyses.

    In comparison to enzymatic or chromogenic detection, Cy3-based fluorescence affords:

    • Higher sensitivity: Linear signal response and minimal substrate diffusion enable detection of low-abundance targets.
    • Multiplexing compatibility: Cy3’s emission spectrum is well-separated from FITC and Cy5, allowing multi-color panels to profile complex tumor ecosystems.
    • Superior quantitation: Digital imaging and cytometry provide precise, reproducible measurement of fluorescence intensity.

    These advantages are further substantiated in the article "Illuminating Translational Breakthroughs: Mechanistic and Strategic Utility of Cy3 Goat Anti-Mouse IgG (H+L) Antibody", which details how this reagent bridges bench discovery with clinical relevance by enabling high-throughput, high-fidelity biomarker mapping in complex biological matrices. Complementing this, the article "Cy3 Goat Anti-Mouse IgG (H+L) Antibody: Advanced Signal Amplification for Tumor Microenvironment Studies" extends the discussion to novel immunoassay strategies for tumor-immune crosstalk, underscoring the unique benefits of fluorescent dye conjugated antibody reagents in revealing microenvironment-driven therapy resistance.

    Troubleshooting and Optimization: Achieving Peak Performance

    Common Challenges and Remedies

    • High background fluorescence: Increase blocking agent concentration or switch to serum from the same species as the host (goat). Validate washing steps and extend wash duration if needed.
    • Weak or inconsistent signal: Optimize secondary antibody dilution (start at 1:500 and titrate). Ensure primary antibody is not limiting and check for proper storage—avoid freeze/thaw cycles and protect from light.
    • Cross-reactivity: Use highly cross-adsorbed secondary antibodies if multiplexing with other species. Confirm that the primary antibody is mouse-derived.
    • Photobleaching: Minimize light exposure during incubation and imaging. Use mounting media containing anti-fade agents.
    • Sample autofluorescence: Select regions free of endogenous pigments, use appropriate controls, and consider spectral unmixing if needed.

    For optimal performance, store the antibody according to manufacturer guidelines: short term at 4°C (up to 2 weeks), and long term at -20°C in the provided antibody storage buffer with sodium azide. Do not freeze-thaw repeatedly, as this may impair antibody binding capacity and fluorescence intensity. The product remains stable for 12 months at -20°C.

    As highlighted in "Redefining Biomarker Discovery: Mechanistic Precision and Technological Strategy", rigorous workflow validation—including control experiments and antibody titration—mitigates variability and maximizes reproducibility, especially in high-throughput or quantitative imaging settings.

    Future Outlook: Expanding the Frontiers of Immunoassay Sensitivity

    The convergence of multiplexed imaging, high-content analysis, and spatial transcriptomics is redefining translational research. The Cy3 Goat Anti-Mouse IgG (H+L) Antibody will remain pivotal in these evolving workflows, enabling researchers to:

    • Profile dynamic protein-protein interactions across diverse tissue contexts, from cancer to metabolic disease models.
    • Integrate quantitative immunofluorescence with single-cell and spatial omics technologies for deeper mechanistic insight.
    • Support the development of next-generation signal amplification antibody platforms, such as tyramide signal amplification (TSA), by serving as an anchor for further amplification steps.

    Emerging applications will require even greater specificity, sensitivity, and multiplexing capability from immunoaffinity purified antibody reagents. APExBIO is committed to ongoing innovation—optimizing antibody conjugation chemistries and validation protocols to meet the rigorous demands of advanced immunoassay and biomarker discovery pipelines.

    Conclusion

    The Cy3 Goat Anti-Mouse IgG (H+L) Antibody offers a robust, versatile, and highly sensitive platform for the detection of mouse primary antibodies in immunofluorescence, flow cytometry, and western blot applications. Its affinity purification and Cy3 labeling deliver superior signal amplification and reproducibility, empowering researchers to tackle complex questions in cancer biology, immunology, and translational medicine. By optimizing protocol variables and leveraging the antibody’s spectral properties, scientists can maximize data quality and accelerate insights from bench to bedside. For detailed product specifications and ordering information, visit the Cy3 Goat Anti-Mouse IgG (H+L) Antibody page at APExBIO.